Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samuel Harry Myers
Observed names:
Samuel H Myers,
Samuel H. Myers
Institutions:
Italian Institute of Technology,
Lo.Li. Pharma S.r.l. (Italy)
Observed institutions:
Edinburgh Cancer Research,
Italian Institute of Technology,
Institute of Genetics and Cancer,
Lo.Li. Pharma S.r.l. (Italy),
University College London,
University of Edinburgh
show all 6
ORCID:
0000-0002-9781-2376
Observed ORCID:
0000-0002-9781-2376
OpenAlex ID:
A5077620492
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
2015
·
Samuel H. Myers
, Valerie G. Brunton
, et al.
·
Journal of Medicinal Chemistry
·
213
PDF
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
2024
·
Viola Previtali
, Greta Bagnolini
, et al.
·
Journal of Medicinal Chemistry
·
85
Questioning PCOS phenotypes for reclassification and tailored therapy
2023
·
Samuel Harry Myers
, Michele Russo
, et al.
·
Trends in Endocrinology and Metabolism
·
72
Synthetic Lethality through the Lens of Medicinal Chemistry
2020
·
Samuel H. Myers
, Jose Antonio Ortega
, et al.
·
Journal of Medicinal Chemistry
·
63
PDF
N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture
2014
·
Jason T. Weiss
, Craig Fraser
, et al.
·
Frontiers in Chemistry
·
33
PDF
PCOS phenotype focus: phenotype D under the magnifying glass
2024
·
Samuel H. Myers
, Mario Montanino Oliva
, et al.
·
Archives of Gynecology and Obstetrics
·
29
Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening
2018
·
Samuel H. Myers
, Carolin Temps
, et al.
·
Journal of Medicinal Chemistry
·
28
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
2023
·
Samuel H. Myers
, Laura Poppi
, et al.
·
European Journal of Medicinal Chemistry
·
27
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
2024
·
Olga Pustotina
, Samuel H. Myers
, et al.
·
Gynecologic and Obstetric Investigation
·
21
PDF
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity
2025
·
Mirco Masi
, Laura Poppi
, et al.
·
Cell Death Discovery
·
20
Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
2019
·
Teresa Valero
, Daniel J. Baillache
, et al.
·
Bioorganic & Medicinal Chemistry
·
19
PDF
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
2025
·
Paola Quaresima
, Samuel H. Myers
, et al.
·
Frontiers in Endocrinology
·
17
PDF
Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity
2019
·
Olga Cruz-López
, Carolin Temps
, et al.
·
ACS Omega
·
17
Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future
2024
·
Antonio Simone Laganà
, Samuel H. Myers
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
14
Has the name PCOS run its course?
2024
·
Samuel H. Myers
, Gianpiero Forte
, et al.
·
Archives of Gynecology and Obstetrics
·
13
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer
2023
·
Francesco Rinaldi
, Fabrizio Schipani
, et al.
·
Angewandte Chemie International Edition
·
11
PDF
Bisphenol A in Water Systems: Risks to Polycystic Ovary Syndrome and Biochar‐Based Adsorption Remediation: A Review
2024
·
Cinzia Michenzi
, Samuel H. Myers
, et al.
·
Chemistry & Biodiversity
·
8
PDF
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
2025
·
Samuel H. Myers
, Christophe O. Soulage
, et al.
·
Gynecologic and Obstetric Investigation
·
7
Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome
2025
·
Arturo Bevilacqua
, Cristiano Giuliani
, et al.
·
Advanced Biology
·
5
PDF
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
2025
·
Cesare Aragona
, Michele Russo
, et al.
·
Health Economics Review
·
4
A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C
2022
·
Robert J. Smith
, Cristina Perez-Ternero
, et al.
·
Journal of Medicinal Chemistry
·
4
PDF
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer
2023
·
Francesco Rinaldi
, Fabrizio Schipani
, et al.
·
Angewandte Chemie
·
3
Four Years of EGOI: Between Science and Clinical Practice on Inositols. Meeting Report ISGE 2024 – EGOI-PCOS Session
2024
·
Lali Pkhaladze
, Zdravko Kamenov
, et al.
·
Gynecologic and Obstetric Investigation
·
2
Correction: Has the name PCOS run its course?
2024
·
Samuel H. Myers
, Gianpiero Forte
, et al.
·
Archives of Gynecology and Obstetrics
·
2
PDF
Preomic profile of BxPC-3 cells after treatment with BRC4
2023
·
Viola Previtali
, Samuel H. Myers
, et al.
·
Journal of Proteomics
·
2
Show more works
View as search
Works count:
28
Citation count:
720
H-index:
13
I10-index:
16
Year
Topic
Type